Episode #43 - Alan Oppenheim, CEO of Ego Pharmaceuticals

December 08, 2019 00:28:25
Episode #43 - Alan Oppenheim, CEO of Ego Pharmaceuticals
Business Beyond Borders
Episode #43 - Alan Oppenheim, CEO of Ego Pharmaceuticals

Dec 08 2019 | 00:28:25

/

Hosted By

Cynthia Dearin

Show Notes

In Episode 43, I talk to Alan Oppenheim, CEO of Ego Pharmaceuticals, an Australian company that exists to improve people’s lives through the science of healthy skin and sells its products around the world including the Middle East, Asia Pacific and the UK.

Ego has won numerous awards for it performance in the export space and it is one of Australia’s great international success stories.

Join Alan and I as we talk about:

• How Ego began on a kitchen table in Victoria, Australia
• Why Alan’s father, Gerald Oppenheim took the company global
• What to look for when choosing a new market to enter
• How to choose an international distributor for your product…
… and much more.

This is an episode with loads of value for anyone working with physical products, especially in the consumer space. Alan is generous with his insights and very easy to listen to.

I hope you enjoy our conversation - it was a pleasure to record.

Other Episodes

Episode

May 08, 2019 00:36:20
Episode Cover

Episode #30 - Vanessa Garrard, Founder of SourceHub Group

In this episode of the Business Beyond Borders podcast, I caught up with Vanessa Garrard who has been ranked in Australia’s Top 30 Female...

Listen

Episode

October 07, 2019 00:30:45
Episode Cover

Episode #40 - Sylvain Mansotte, CEO & Co-Founder at Whispli

What do you do when you uncover fraud at your workplace? Do you speak up, or brush it under the carpet and hope it...

Listen

Episode 68

June 16, 2026 00:37:07
Episode Cover

Episode #68: Why Smart Money Chooses Cities Before It Chooses Companies with Jason de Sousa

When businesses expand internationally, most attention goes to entrepreneurs, products, and markets. But behind every successful expansion lies something far less visible: infrastructure. In...

Listen